Success Metrics

Clinical Success Rate
89.1%

Based on 49 completed trials

Completion Rate
89%(49/55)
Active Trials
14(14%)
Results Posted
37%(18 trials)
Terminated
6(6%)

Phase Distribution

Ph not_applicable
24
24%
Ph phase_2
12
12%
Ph early_phase_1
2
2%
Ph phase_4
21
21%
Ph phase_1
10
10%
Ph phase_3
19
19%

Phase Distribution

12

Early Stage

12

Mid Stage

40

Late Stage

Phase Distribution88 total trials
Early Phase 1First-in-human
2(2.3%)
Phase 1Safety & dosage
10(11.4%)
Phase 2Efficacy & side effects
12(13.6%)
Phase 3Large-scale testing
19(21.6%)
Phase 4Post-market surveillance
21(23.9%)
N/ANon-phased studies
24(27.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.7%

49 of 60 finished

Non-Completion Rate

18.3%

11 ended early

Currently Active

14

trials recruiting

Total Trials

98

all time

Status Distribution
Active(22)
Completed(49)
Terminated(11)
Other(16)

Detailed Status

Completed49
unknown15
Recruiting10
Not yet recruiting6
Terminated6
Withdrawn5

Development Timeline

Analytics

Development Status

Total Trials
98
Active
14
Success Rate
89.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (2.3%)
Phase 110 (11.4%)
Phase 212 (13.6%)
Phase 319 (21.6%)
Phase 421 (23.9%)
N/A24 (27.3%)

Trials by Status

completed4950%
not_yet_recruiting66%
active_not_recruiting44%
unknown1515%
recruiting1010%
enrolling_by_invitation22%
suspended11%
terminated66%
withdrawn55%

Recent Activity

Clinical Trials (98)

Showing 20 of 98 trialsScroll for more
NCT05924191Not Applicable

Preventive Effect of Photobiomodulation in the Postoperative Period of Extractions of Retained Lower Third Molars

Completed
NCT07704398Not Applicable

Effect of Corticosteroid Injection in Symptomatic Pulpitis Cases

Completed
NCT06780085Phase 2

A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)

Recruiting
NCT05819541Phase 2

Treating Exacerbations of Asthma With Oral Montelukast in Children

Completed
NCT07675291Not Applicable

Rituximab Combining With Low-Dose Mycophenolate Mofetil on Proliferative Lupus Nephritis in Children

Not Yet Recruiting
NCT07039019Early Phase 1

Study of the Feasibility and Efficacy of PrednisonE for Non-specifiC pleuriTis

Recruiting
NCT05789589Phase 1

Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases

Suspended
NCT07546097Phase 4

Comparative Effectiveness of Upadacitinib vs Corticosteroids as First-Line Therapy for Acute Severe Ulcerative Colitis(UPFRONT)

Recruiting
NCT07611214Phase 4

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

Recruiting
NCT05660421Phase 2

Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint Inhibitors

Withdrawn
NCT04381936Phase 3

Randomised Evaluation of COVID-19 Therapy

Recruiting
NCT07513142Phase 4

PPP Versus Corticosteroid for Thigh Muscle Injuries

Enrolling By Invitation
NCT07474714Phase 3

Hyaluronic Acid Injection in Idiopathic Carpal Tunnel Syndrome; is it Effective as Local Corticosteroids

Not Yet Recruiting
NCT05844930Phase 4

A Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft (ActiveMatrix) Verses Standard of Care in Adhesive Capsulitis of the Shoulder

Completed
NCT07199192Phase 4

Steroid Treatment for Severe Acute Respiratory Infection (STAR) Trial

Not Yet Recruiting
NCT05603468Phase 4

Effect of PRP vs Corticosteroid in Rotator Cuff Tendinopathy Subtypes in Arthroscopic Repair

Active Not Recruiting
NCT07223580Phase 4

A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi

Recruiting
NCT06712290Not Applicable

Connective Tissue Matrix Compared to Steroid Injections for Rotator Cuff Tendinopathy

Withdrawn
NCT04477629Phase 2

Belatacept in De Novo Heart Transplantation

Recruiting
NCT06279078

Long-term Effect of Steroid on Metabolic Diseases in Asthmatics

Completed

Drug Details

Intervention Type
DRUG
Total Trials
98